Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,901 | 150,072 | 141,139 | 132,953 | 128,994 |
| Marketable Securities | 236,949 | 241,402 | 229,063 | 217,617 | 213,591 |
| Receivables | 204,494 | 204,701 | 212,229 | 212,072 | 188,318 |
| Inventories | 158,034 | 168,468 | 175,688 | 183,759 | 188,833 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 39,829 |
| Other current assets | 91,206 | 63,457 | 62,991 | 62,605 | 62,069 |
| TOTAL | $845,584 | $828,100 | $821,110 | $809,006 | $821,634 |
| Non-Current Assets | |||||
| PPE Net | 357,422 | 349,664 | 347,161 | 343,010 | 333,026 |
| Intangibles | 46,155 | 228,518 | 230,386 | 235,198 | 234,843 |
| Other Non-Current Assets | 281,543 | 94,088 | 90,584 | 91,433 | 85,490 |
| TOTAL | $685,120 | $672,270 | $668,131 | $669,641 | $653,359 |
| Total Assets | $1,530,704 | $1,500,370 | $1,489,241 | $1,478,647 | $1,474,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60,057 | 44,127 | 50,085 | 52,458 | 52,648 |
| Accrued Expenses | 236,131 | 202,074 | 188,842 | 178,267 | 205,530 |
| TOTAL | $934,568 | $760,208 | $822,776 | $878,668 | $856,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 593,110 | 630,011 | 597,958 | 600,021 | 597,085 |
| Deferred Revenues | 27,380 | 26,007 | 25,849 | 25,943 | 25,583 |
| Other Non-Current Liabilities | 38,935 | 34,597 | 30,324 | 30,355 | 28,657 |
| TOTAL | $704,349 | $685,176 | $674,963 | $673,766 | $702,227 |
| Total Liabilities | $1,638,917 | $1,445,384 | $1,497,739 | $1,552,434 | $1,558,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,005 | 89,658 | 89,541 | 89,531 | 89,638 |
| Common Shares | 10,334 | 10,312 | 10,283 | 10,255 | 10,258 |
| Retained earnings | 540,401 | 488,033 | 431,577 | 364,375 | 318,356 |
| Other shareholders' equity | -37,843 | -29,658 | -29,718 | -32,360 | -37,143 |
| TOTAL | $-108,213 | $54,986 | $-8,498 | $-73,787 | $-83,995 |
| Total Liabilities And Equity | $1,530,704 | $1,500,370 | $1,489,241 | $1,478,647 | $1,474,993 |